Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring - JAMA Network
jamanetwork.comSubmitted by jamanetworkcom5065 in health
This randomized clinical trial compares the effect of magnesium sulfate administered intravenously vs placebo on the outcome of death or cerebral palsy at 2 years in pregnant individuals expected to deliver at 30 to 34 weeks’ gestation.